| November 23, 2010 |
Amorfix Announces Success in Generating High Affinity Antibodies to Cancer Specific Epitopes |
| October 21, 2010 |
Amorfix Life Sciences and Biotrofix Announces Detection of Aggregated Beta-Amyloid in CSF Using the A4 Alzheimer's Test |
| October 20, 2010 |
Amorfix Life Sciences Appoints Dr. Walter Von Wartburg to Board of Directors and Enhances Business Development Activities |
| October 7, 2010 |
Amorfix Life Sciences Announces Membership in Alzheimer's Disease Neuroimaging Initiative (ADNI) |
| September 16, 2010 |
Amorfix Life Sciences Announces Publication of A4 Data in Prestigious Journal of Alzheimer's Disease and Provides Update on Management Changes |
| August 16, 2010 |
Early Warning Report Issued Pursuant to National Instrument 62-103 Acquisition of Shares of Amorfix Life Sciences |
| August 12, 2010 |
Amorfix Announces First Quarter Fiscal 2011 Results |
| July 22, 2010 |
Conference Call to Review Recent Business Development Activities and Near-Term Company Goals |
| July 14, 2010 |
Amorfix Life Sciences Announces Global Licensing Agreement For The Treatment of ALS with Biogen Idec |
| July 12, 2010 |
Amorfix A4 Assay Provides New Insights Into Alzheimer's Disease Pre-Clinical Development Mouse Models |
| July 6, 2010 |
Amorfix and reMYND announces testing service agreement for the A4 Alzheimer's Test |
| June 24, 2010 |
Amorfix and QED Bioscience announce agreement to develop novel monoclonal antibodies for cancer |
| June 3, 2010 |
Amorfix Life Sciences and Prevent announce global licensing agreement for the treatment of ALS |
| June 2, 2010 |
Amorfix announces management change and product development plans for fiscal 2011 |
| May 31, 2010 |
Corporate update on vCJD test development |
| May 28, 2010 |
Amorfix and Aragen Bioscience enter into agreement to develop novel monoclonal antibodies for the treatment of cancers |
| May 11, 2010 |
Amorfix and Epitomics enter into agreement to develop novel monoclonal antibodies against disease specific epitopes for the treatment of cancerst |
| May 4, 2010 |
Amorfix Life Sciences announces world's first detection of aggregated beta-amyloid in blood using the Alzheimer's diagnostic A4 Assay |
| February 8, 2010 |
Amorfix announces third quarter 2010 results |
| January 6, 2010 |
Biopharmaceutical executive, Dr. Robert Gundel, joins Amorfix as vice president, research & development |